VIVUS Reports First Quarter 2015 Financial Results

Go back to VIVUS Reports First Quarter 2015 Financial Results

Vivus (VVUS) Sales Flat But Opportunities Abound, RBC Capital Says

May 6, 2015 12:18 PM EDT

RBC Capital maintains an Outperform rating on Vivus (NASDAQ: VVUS) with the price target set at $6 following Q1 results which showed flat Qsymia sales. Vivus is also looking to expand into additional indications. Vivus plans to conduct phase III trials of Qsymia in... More

VIVUS (VVUS) Tops Q1 EPS by 7c

May 5, 2015 4:03 PM EDT

VIVUS (NASDAQ: VVUS) reported Q1 EPS of ($0.15), $0.07 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $21.8 million.

For earnings history and earnings-related data on VIVUS (VVUS) click here.

... More